Literature DB >> 26880765

T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function.

Yanbao Xiong1, Sarwat Ahmad2, Daiki Iwami1, C Colin Brinkman1, Jonathan S Bromberg3.   

Abstract

T-bet is essential for natural regulatory T cells (nTreg) to regulate Th1 inflammation, but whether T-bet controls other Treg functions after entering the inflammatory site is unknown. In an islet allograft model, T-bet(-/-) nTreg, but not induced Treg, failed to prolong graft survival as effectively as wild-type Treg. T-bet(-/-) nTreg had no functional deficiency in vitro but failed to home from the graft to draining lymph nodes (dLN) as efficiently as wild type. T-bet regulated expression of adhesion- and migration-related molecules, influencing nTreg distribution in tissues, so that T-bet(-/-) nTreg remained in the grafts rather than migrating to lymphatics and dLN. In contrast, both wild-type and T-bet(-/-) CD4(+) conventional T cells and induced Treg migrated normally toward afferent lymphatics. T-bet(-/-) nTreg displayed instability in the graft, failing to suppress Ag-specific CD4(+) T cells and prevent their infiltration into the graft and dLN. Thus, T-bet regulates nTreg migration into afferent lymphatics and dLN and consequently their suppressive stability in vivo.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26880765      PMCID: PMC4779695          DOI: 10.4049/jimmunol.1502537

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.

Authors:  Levi G Ledgerwood; Girdhari Lal; Nan Zhang; Alexandre Garin; Steven J Esses; Florent Ginhoux; Miriam Merad; Helene Peche; Sergio A Lira; Yaozhong Ding; Yu Yang; Xingxuan He; Edward H Schuchman; Maria L Allende; Jordi C Ochando; Jonathan S Bromberg
Journal:  Nat Immunol       Date:  2007-11-25       Impact factor: 25.606

2.  T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.

Authors:  Jonathan H Esensten; Michael R Lee; Laurie H Glimcher; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

3.  Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation.

Authors:  Girdhari Lal; Nan Zhang; William van der Touw; Yaozhong Ding; Wenjun Ju; Erwin P Bottinger; St Patrick Reid; David E Levy; Jonathan S Bromberg
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

4.  Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin.

Authors:  Andrew M Intlekofer; Arnob Banerjee; Naofumi Takemoto; Scott M Gordon; Caitlin S Dejong; Haina Shin; Christopher A Hunter; E John Wherry; Tullia Lindsten; Steven L Reiner
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

5.  Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Authors:  Nan Zhang; Bernd Schröppel; Girdhari Lal; Claudia Jakubzick; Xia Mao; Dan Chen; Na Yin; Rolf Jessberger; Jordi C Ochando; Yaozhong Ding; Jonathan S Bromberg
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

6.  The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.

Authors:  Meghan A Koch; Glady's Tucker-Heard; Nikole R Perdue; Justin R Killebrew; Kevin B Urdahl; Daniel J Campbell
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

7.  The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR.

Authors:  Guangwei Liu; Samir Burns; Gonghua Huang; Kelli Boyd; Richard L Proia; Richard A Flavell; Hongbo Chi
Journal:  Nat Immunol       Date:  2009-05-31       Impact factor: 25.606

8.  Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells.

Authors:  Irina L Grigorova; Susan R Schwab; Tri Giang Phan; Trung H M Pham; Takaharu Okada; Jason G Cyster
Journal:  Nat Immunol       Date:  2008-12-07       Impact factor: 25.606

9.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.

Authors:  Ye Zheng; Ashutosh Chaudhry; Arnold Kas; Paul deRoos; Jeong M Kim; Tin-Tin Chu; Lynn Corcoran; Piper Treuting; Ulf Klein; Alexander Y Rudensky
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

10.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.

Authors:  Mahesh Yadav; Cedric Louvet; Dan Davini; James M Gardner; Marc Martinez-Llordella; Samantha Bailey-Bucktrout; Bryan A Anthony; Francis M Sverdrup; Richard Head; Daniel J Kuster; Peter Ruminski; David Weiss; David Von Schack; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2012-09-10       Impact factor: 14.307

View more
  21 in total

Review 1.  Harnessing the lymph node microenvironment.

Authors:  Natalie A O'Neill; Haleigh B Eppler; Christopher M Jewell; Jonathan S Bromberg
Journal:  Curr Opin Organ Transplant       Date:  2018-02       Impact factor: 2.640

2.  A wave of Foxp3+ regulatory T cell accumulation in the neonatal liver plays unique roles in maintaining self-tolerance.

Authors:  Mingyang Li; Weijia Zhao; Yifan Wang; Lixue Jin; Gaowen Jin; Xiuyuan Sun; Wei Wang; Ke Wang; Xi Xu; Jie Hao; Rong Jin; Wenxian Fu; Ying Sun; Yingjun Chang; Xiaojun Huang; Xuyu Zhou; Hounan Wu; Kunshan Zhang; Qing Ge
Journal:  Cell Mol Immunol       Date:  2019-06-06       Impact factor: 11.530

3.  Singular role for T-BET+CXCR3+ regulatory T cells in protection from autoimmune diabetes.

Authors:  Tze Guan Tan; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

Review 4.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

5.  Type 1 Treg cells promote the generation of CD8+ tissue-resident memory T cells.

Authors:  Cristina Ferreira; Leandro Barros; Marta Baptista; Birte Blankenhaus; André Barros; Patrícia Figueiredo-Campos; Špela Konjar; Alexandra Lainé; Nadine Kamenjarin; Ana Stojanovic; Adelheid Cerwenka; Hans C Probst; Julien C Marie; Marc Veldhoen
Journal:  Nat Immunol       Date:  2020-05-18       Impact factor: 25.606

6.  CD4 T cell sphingosine 1-phosphate receptor (S1PR)1 and S1PR4 and endothelial S1PR2 regulate afferent lymphatic migration.

Authors:  Yanbao Xiong; Wenji Piao; C Colin Brinkman; Lushen Li; Joseph M Kulinski; Ana Olivera; Andreane Cartier; Timothy Hla; Keli L Hippen; Bruce R Blazar; Susan R Schwab; Jonathan S Bromberg
Journal:  Sci Immunol       Date:  2019-03-15

7.  Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses.

Authors:  Vikas Saxena; Wenji Piao; Lushen Li; Christina Paluskievicz; Yanbao Xiong; Thomas Simon; Ram Lakhan; C Colin Brinkman; Sarah Walden; Keli L Hippen; Marina WillsonShirkey; Young S Lee; Chelsea Wagner; Bruce R Blazar; Jonathan S Bromberg
Journal:  Cell Rep       Date:  2022-04-19       Impact factor: 9.995

Review 8.  T Cell Trafficking through Lymphatic Vessels.

Authors:  Morgan C Hunter; Alvaro Teijeira; Cornelia Halin
Journal:  Front Immunol       Date:  2016-12-21       Impact factor: 7.561

Review 9.  Unique Features of Pancreatic-Resident Regulatory T Cells in Autoimmune Type 1 Diabetes.

Authors:  Jingli Lu; Chaoqi Zhang; Lifeng Li; Wenhua Xue; Chengliang Zhang; Xiaojian Zhang
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

Review 10.  Structure and Immune Function of Afferent Lymphatics and Their Mechanistic Contribution to Dendritic Cell and T Cell Trafficking.

Authors:  Jorge Arasa; Victor Collado-Diaz; Cornelia Halin
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.